Tenofovir alafenamide versus tenofovir disoproxil fumarate for the treatment of HBeAg-positive chronic hepatitis B virus infection: a randomised, double-blind, phase 3, non-inferiority trial

著者: Henry Lik‐Yuen Chan, Scott Fung, Wai Kay Seto, Wan‐Long Chuang, Chi-Yi Chen, Hyung Joon Kim, Aric J. Hui, Harry L.A. Janssen, Abhijit Chowdhury, Tak Yin Owen Tsang, Rajiv Mehta, Edward Gane, John F. Flaherty, Benedetta Massetto, Anuj Gaggar, Kathryn M. Kitrinos, Lanjia Lin, G. Mani Subramanian, John G. McHutchison, Young‐Suk Lim, Subrat Kumar Acharya, Kosh Agarwal - The Lancet 2016 被引用: 458